Sweet syndrome after the first dose of SARS-CoV-2 vaccine (Pfizer-BioNTech)

被引：2
|
作者：
Kim, Min Jae [1 ]
Kim, Jee Woo [1 ]
Na, Jung-Im [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Dermatol, Seongnam, South Korea
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 12期
关键词：
D O I：
10.1111/dth.15915
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
    Reynolds, Lia
    Dewey, Cate
    Asfour, Ghaid
    Little, Matthew
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [42] Eruptive angiomatosis after SARS-CoV-2 vaccine (Comirnaty, Pfizer)
    Zengarini, C.
    Misciali, C.
    Lazzarotto, T.
    Dika, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (02) : E90 - E91
  • [43] Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine
    Ben Salah, N.
    Korbi, M.
    Ben Fadhel, N.
    Safa, I.
    Chad, F.
    Njima, M.
    Belhadjali, H.
    Amri, M.
    Aouem, K.
    Zili, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : E873 - E875
  • [44] MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
    Obata, Shota
    Hidaka, Sumi
    Yamano, Mizuki
    Yanai, Mitsuru
    Ishioka, Kunihiro
    Kobayashi, Shuzo
    CLINICAL KIDNEY JOURNAL, 2022, 15 (02) : 357 - 359
  • [45] Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
    Kaiser, Robert A.
    Haller, Maria C.
    Apfalter, Petra
    Kerschner, Heidrun
    Cejka, Daniel
    KIDNEY INTERNATIONAL, 2021, 100 (03) : 697 - 698
  • [46] Antibodies to spike protein of SARS-CoV-2 in convalescent COVID19 patients and subjects immunized with Sinopharm, Pfizer-BioNTech or Sputnik V vaccine
    Marinkovic, Milos
    Petrovic, Ivana
    Mihaljevic, Olgica
    Stanojevic, Marijana
    Simonovic, Snezana Zivancevic
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 361 - 361
  • [47] Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2
    Navas, Leandra J. Robles
    Huete, Juan J. Ortega
    Sanchis, Maria L. Julia
    Miro, Jorge S. Bravo
    Sanchez, Serezade Cervera
    Gasset, Ricardo Molina
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (03): : 298 - 302
  • [48] Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination
    Algaissi, Abdullah
    Alamer, Edrous
    Jeraiby, Mohammed
    Alomaish, Abeer
    Elrhima, Omer
    Qumayi, Sultan
    Qasir, Naaif A.
    Areeshi, Halima
    Masmali, Asma
    Alhazmi, Abdulaziz
    SAUDI MEDICAL JOURNAL, 2022, 43 (06) : 567 - 571
  • [49] Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty®])
    Ando, Masaru
    Satonaga, Yoshio
    Takaki, Ryuichiro
    Yabe, Michitoshi
    Kan, Takamasa
    Omote, Erika
    Yamasaki, Toru
    Komiya, Kosaku
    Hiramatsu, Kazufumi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : 187 - 189
  • [50] First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
    Havla, Joachim
    Schultz, Yannick
    Zimmermann, Hanna
    Hohlfeld, Reinhard
    Danek, Adrian
    Kumpfel, Tania
    JOURNAL OF NEUROLOGY, 2022, 269 (01) : 55 - 58
12345